Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
466580011000036112 | Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
466581011000036117 | Plasma-Lyte 148 Replacement (magnesium chloride 300 mg / 1 L + potassium chloride 370 mg / 1 L + sodium acetate trihydrate 3.68 g / 1 L + sodium chloride 5.26 g / 1 L + sodium gluconate 5.02 g / 1 L) intravenous infusion injection, 1 L bag (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Is a | trade product unit of use | false | Inferred relationship | Some | ||
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Is a | Plasma-Lyte 148 Replacement | false | Inferred relationship | Some | ||
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Is a | sodium gluconate 5.02 g/L + sodium chloride 5.26 g/L + potassium chloride 370 mg (potassium 5 mmol)/L + magnesium chloride 300 mg (magnesium 1.5 mmol)/L + sodium acetate trihydrate 3.68 g/L injection, bag | false | Inferred relationship | Some | ||
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has manufactured dose form | intravenous infusion injection | false | Inferred relationship | Some | ||
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has Australian BoSS | sodium chloride | false | Inferred relationship | Some | 769130254 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has Australian BoSS | sodium gluconate | false | Inferred relationship | Some | 737701138 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has intended active ingredient | magnesium chloride | false | Inferred relationship | Some | 132937970 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has intended active ingredient | sodium gluconate | false | Inferred relationship | Some | 737701138 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has Australian BoSS | magnesium chloride | false | Inferred relationship | Some | 132937970 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has unit of use | bag | false | Inferred relationship | Some | ||
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has intended active ingredient | potassium chloride | false | Inferred relationship | Some | 746478574 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has Australian BoSS | potassium chloride | false | Inferred relationship | Some | 746478574 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has intended active ingredient | sodium chloride | false | Inferred relationship | Some | 769130254 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has intended active ingredient | sodium acetate trihydrate | false | Inferred relationship | Some | 577512898 | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has Australian BoSS | sodium acetate trihydrate | false | Inferred relationship | Some | 577512898 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has TPUU | False | Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Inferred relationship | Some | |
Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | has TPUU | False | Plasma-Lyte 148 Replacement intravenous infusion injection, 1 L bag | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set